End‐stage renal disease and non‐narcotic analgesics: a case‐control study.
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
1. To assess the risk of end‐stage renal disease (ESRD) associated with the regular use of three classes of non‐narcotic analgesics, we performed a case‐control study of 340 patients with ESRD on a haemodialysis maintenance program and 673 hospital controls. 2. The overall odds ratio estimate for non‐narcotic analgesics taken at least every other day for 30 days or longer before the first symptom of renal disease was 2.89 (95% CI, 1.78 to 4.68). 3. The risk increased in relation to the use duration. 4. The previous regular consumption of combinations containing phenacetin was strongly associated with ESRD (odds ratio, 19.05; 95% CI, 2.31 to 157.4). The odds ratio for previous regular consumption of salicylates was 2.54 (95% CI, 1.24 to 5.20) and for pyrazolones 2.16 (95% CI, 0.87 to 5.32). 5. An analysis for possible confounding by a history of repeated headaches, arthritis, kidney stones, hypertension, and diabetes did not alter the results. 6. The odds ratio estimates for different pathological subgroups of ESRD patients in relation to previous use of any non‐narcotic analgesic were glomerulonephritis. 10.57 (95% CI, 1.25 to 89.0), interstitial nephritis, 3.33 (95% CI, 1.21 to 9.17), cystic kidney disease, 0.71 (95% CI, 0.25 to 1.97), and unknown, 5.15 (95% CI, 2.29‐11.57). 7. The results of this study suggest that the regular consumption of analgesics should be routinely considered as a risk factor for any non‐ congenital cause of chronic renal failure. They also suggest that the risk of ESRD associated with the regular consumption of phenacetin is much higher than the risk associated with other non‐narcotic analgesics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analgesic Nephropathy: A Reassessment of the Role of Phenacetin and Other Analgesics
Prescott, L. F. (1982) · Drugs · doi:10.2165/00003495-198223010-00004 · Cited by 137
Cited by
Chronic kidney disease: the global challenge
El Nahas, A. M., & Bello, A. K. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17789-7 · Cited by 1,195
Perneger, T. V., Whelton, P. K., & Klag, M. J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412223312502 · Cited by 484
NSAID Use and Progression of Chronic Kidney Disease
Gooch, K., Culleton, B. F., Manns, B. J., Zhang, J., Alfonso, H., Tonelli, M., Frank, C., Klarenbach, S., & Hemmelgarn, B. R. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.02.015 · Cited by 333
Nonsteroidal Anti-Inflammatory Drugs and the Kidney
Hörl, W. H. (2010) · Pharmaceuticals · doi:10.3390/ph3072291 · Cited by 298
Acetaminophen, Aspirin, and Chronic Renal Failure
Fored, C. M., Ejerblad, E., Lindblad, P., Fryzek, J. P., Dickman, P. W., Signorello, L. B., Lipworth, L., Elinder, C.-G., Blot, W. J., McLaughlin, J. K., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010323 · Cited by 292
Metadata
- Authors
- Morlans, M., Laporte, Jr., Vidal, X., Cabeza, D., & Stolley, P.
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 1990-11
- Volume
- 30
- Issue
- 5
- Pages
- 717-723
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W1976785116
- Cited by
- 101
- References
- 1
- FWCI
- 3.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: End‐stage renal disease and non‐narcotic analgesics: a case‐control study. https://app.cochat.ai/papers/10.1111/j.1365-2125.1990.tb03841.x
- The paper
- Morlans, M., Laporte, Jr., Vidal, X., Cabeza, D., & Stolley, P. (1990). End‐stage renal disease and non‐narcotic analgesics: a case‐control study. British Journal of Clinical Pharmacology. https://doi.org/10.1111/j.1365-2125.1990.tb03841.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.